Models of Hepatic Elimination: Comparison of Stochastic Models to Describe Residence Time Distributions and to Predict the Influence of Drug Distribution, Enzyme Heterogeneity, and Systemic Recycling on Hepatic Elimination

Overview

Journal J Pharmacokinet Biopharm

Specialty Pharmacology

Date 1988 Feb 1

PMID 3373419

Citations 35

Authors

M S Roberts

J D Donaldson

M Rowland

Affiliations

Soon will be listed here.

Abstract

The residence time distribution of noneliminated solutes in the liver can be represented by a variety of stochastic models. The dispersion model (closed and mixed boundary conditions), gamma distribution, log normal distribution and normal distribution models were used to describe output concentration-time profiles after bolus injections into the liver of labeled erythrocytes and albumin. The dispersion model and log normal distribution model provide the best representation of the data and give similar estimates of relative dispersion and availability for varying hepatocellular enzyme activity. The availability of solutes eliminated from the liver by first-order kinetics is determined by the residence time distribution of the solute in the liver and not on events occurring in the liver when a uniform enzyme distribution is assumed. Both enzyme heterogeneity (axial or transverse) and hepatocyte permeability may affect solute availability. A more complex model accounting for enzyme distribution and the micromixing of solute within the liver is required for solutes undergoing saturable kinetics.

Citing Articles

A Complete Extension of Classical Hepatic Clearance Models Using Fractional Distribution Parameter f in Physiologically Based Pharmacokinetics.

Jeong Y, Jusko W J Pharm Sci. 2023; 113(1):95-117.

PMID: 37279835 PMC: 10902797. DOI: 10.1016/j.xphs.2023.05.019.

A gamma-distribution convolution model of Tc-MIBI thyroid time-activity curves.

Wesolowski C, Wanasundara S, Wesolowski M, Erbas B, Babyn P EJNMMI Phys. 2016; 3(1):31.

PMID: 27987183 PMC: 5161052. DOI: 10.1186/s40658-016-0166-z.

Understanding the hysteresis loop conundrum in pharmacokinetic/pharmacodynamic relationships.

Louizos C, Yanez J, Forrest M, Davies N J Pharm Pharm Sci. 2014; 17(1):34-91.

PMID: 24735761 PMC: 4332569.

Reassessing models of hepatic extraction.

Ridgway D, Tuszynski J, Tam Y J Biol Phys. 2013; 29(1):1-21.

PMID: 23345816 PMC: 3456842. DOI: 10.1023/A:1022531403741.

Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.

Li P, Robertson T, Zhang Q, Fletcher L, Crawford D, Weiss M Pharm Res. 2012; 29(6):1658-69.

PMID: 22302523 DOI: 10.1007/s11095-012-0690-z.

References

Bass L . Flow dependence of first-order uptake of substances by heterogeneous perfused organs. J Theor Biol. 1980; 86(2):365-76. DOI: 10.1016/0022-5193(80)90012-0. View

Ahmad A, Bennett P, Rowland M . Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models. J Pharm Pharmacol. 1983; 35(4):219-24. DOI: 10.1111/j.2042-7158.1983.tb02916.x. View

Bass L . Convection-dispersion modeling of hepatic elimination. J Pharm Sci. 1986; 75(3):321-2. DOI: 10.1002/jps.2600750325. View

Pedersen P . Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT. J Pharmacokinet Biopharm. 1977; 5(5):513-31. DOI: 10.1007/BF01061732. View

Roberts M, Rowland M . A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations. J Pharmacokinet Biopharm. 1986; 14(3):227-60. DOI: 10.1007/BF01106706. View

Wise M . Tracer dilution curves in cardiology and random walk and lognormal distributions. Acta Physiol Pharmacol Neerl. 1966; 14(2):175-204. View

FORKER E, Luxon B . Albumin binding and hepatic uptake: the importance of model selection. J Pharm Sci. 1983; 72(10):1232-3. DOI: 10.1002/jps.2600721038. View

Rose C, GORESKY C . Vasomotor control of capillary transit time heterogeneity in the canine coronary circulation. Circ Res. 1976; 39(4):541-54. DOI: 10.1161/01.res.39.4.541. View

Zierler K . THEORY OF THE USE OF ARTERIOVENOUS CONCENTRATION DIFFERENCES FOR MEASURING METABOLISM IN STEADY AND NON-STEADY STATES. J Clin Invest. 1961; 40(12):2111-25. PMC: 290918. DOI: 10.1172/JCI104437. View

10.

Gumucio J, Miller D . Functional implications of liver cell heterogeneity. Gastroenterology. 1981; 80(2):393-403. View

11.

Keiding S, Chiarantini E . Effect of sinusoidal perfusion on galactose elimination kinetics in perfused rat liver. J Pharmacol Exp Ther. 1978; 205(2):465-70. View

12.

Roberts M, Rowland M . A dispersion model of hepatic elimination: 2. Steady-state considerations--influence of hepatic blood flow, binding within blood, and hepatocellular enzyme activity. J Pharmacokinet Biopharm. 1986; 14(3):261-88. DOI: 10.1007/BF01106707. View

13.

Pang K, Rowland M . Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation. J Pharmacokinet Biopharm. 1977; 5(6):655-80. DOI: 10.1007/BF01059689. View

14.

GORESKY C, Bach G, Nadeau B . On the uptake of materials by the intact liver. The transport and net removal of galactose. J Clin Invest. 1973; 52(5):991-1009. PMC: 302353. DOI: 10.1172/JCI107300. View

15.

Bass L, Robinson P, Bracken A . Hepatic elimination of flowing substrates: the distributed model. J Theor Biol. 1978; 72(1):161-84. DOI: 10.1016/0022-5193(78)90023-1. View

16.

Sawada Y, Sugiyama Y, Miyamoto Y, Iga T, Hanano M . Hepatic drug clearance model: comparison among the distributed, parallel-tube and well-stirred models. Chem Pharm Bull (Tokyo). 1985; 33(1):319-26. DOI: 10.1248/cpb.33.319. View

17.

GORESKY C . Kinetic interpretation of hepatic multiple-indicator dilution studies. Am J Physiol. 1983; 245(1):G1-12. DOI: 10.1152/ajpgi.1983.245.1.G1. View

18.

Pang K, STILLWELL R . An understanding of the role of enzyme localization of the liver on metabolite kinetics: a computer simulation. J Pharmacokinet Biopharm. 1983; 11(5):451-68. DOI: 10.1007/BF01062205. View

19.

FORKER E, Luxon B . Hepatic transport kinetics: effect of anatomic and metabolic heterogeneity on estimates of the average transfer coefficients. Am J Physiol. 1982; 243(6):G532-40. DOI: 10.1152/ajpgi.1982.243.6.G532. View

20.

Keiding S, Steiness E . Flow dependence of propranolol elimination in perfused rat liver. J Pharmacol Exp Ther. 1984; 230(2):474-7. View